OTCM
IONM
Market cap0kUSD
Sep 21, Last price
0.00USD
Name
Assure Holdings Corp
Chart & performance
P/E
—
P/S
0.00
EPS
—
Div yield, %
—
Shrs. gr., 5y
56.93%
Rev. gr., 5y
-55.62%
Revenues
255k
-45.86%
Net income
-26m
L-13.40%
CFO
-5m
L-37.22%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Assure Holdings Corp., through its various subsidiaries, specializes in delivering expert technical and professional support for intraoperative neuromonitoring (IONM), predominantly during complex spine and cranial surgical procedures. The company offers a comprehensive suite of clinical and operational services, which encompass the coordination of interoperative neurophysiologists and supervising practitioners, continuous real-time neural monitoring, patient advocacy, and all necessary billing services. These offerings are designed to assist surgeons and healthcare institutions throughout invasive medical interventions. Assure Holdings maintains an active presence across numerous U.S. states, including Arizona, Colorado, Kansas, Louisiana, Michigan, Missouri, Nebraska, Nevada, Pennsylvania, South Carolina, Texas, and Utah. Its corporate headquarters are situated in Englewood, Colorado.
IPO date
Jul 17, 2017
Employees
127
Domiciled in
US
Incorporated in
US
Legal address
C/O The Corporation Trust Company of Nevada
701 South Carson Street
Suite 200
Carson City, NV 89701
US
701 South Carson Street
Suite 200
Carson City, NV 89701
US
Headquarters
8133 Leesburg Pike
Vienna, VA 22182
US
Vienna, VA 22182
US
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||